Platelet inhibition with ticagrelor for left ventricular assist device thrombosis
- PMID: 25991808
- PMCID: PMC4441041
- DOI: 10.1161/CIRCHEARTFAILURE.115.002096
Platelet inhibition with ticagrelor for left ventricular assist device thrombosis
Keywords: platelet aggregation inhibitor; thrombosis; ticagrelor; ventricular assist device.
Figures
References
-
- Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA, Rame JE, Acker MA, Blackstone EH, Ehrlinger J, Thuita L, Mountis MM, Soltesz EG, Lytle BW, Smedira NG. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med. 2014;370:33–40. - PubMed
-
- Wang JX, Lee EH, Bonde P. Over 400% increase in lvad thrombosis reported to the fda’s manufacturer and user facility device experience (maude) database from 2010 to 2012. J Heart Lung Transplant. 2014;33:S9–S10.
-
- Mehra MR, Stewart GC, Uber PA. The vexing problem of thrombosis in long-term mechanical circulatory support. J Heart Lung Transplant. 2014;33:1–11. - PubMed
-
- Ledford ID, Labedi M, Kfoury AG, Stehlik J, Alharethi R, Reid BB, Budge D, Selzman CH, Revelo MP, Stoker S, Bader F, Miller DV. Thrombus within the heartmate ii left ventricular assist device (LVAD): Are all clots created equal? J Heart Lung Transplant. 2012;31:S85–S86.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
